Variability of the Unique Fiber Potentials of a Spastic Muscle Treated With Botulinum Toxin

Korábbi kezelés

• The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
• History of proven NMJ disorder (Myasthenia, Lambert Eaton's Syndrome), patient treated with anticholinesterase drugs
• The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
• History of proven NMJ disorder (Myasthenia, Lambert Eaton's Syndrome), patient treated with anticholinesterase drugs
• The subject will be excluded if abnormalities will be found on prior EMG
  • Control Subjects :
• The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
• History of proven NMJ disorder (Myasthenia, Lambert Eaton's Syndrome), patient treated with anticholinesterase drugs
• The subject will be excluded if abnormalities will be found on prior EMG

Más betegség

• Other upper limb disorders (bilateral stroke, peripheral neuropathy, peripheral nerve injury (s), nerve compression syndrome, myopathy, severe osteoarthritis, recent muscle injury (s), recent bone, fracture, joint replacement)
• Ongoing conditions contraindicating BTA treatment (especially respiratory disease)
• Psychiatric disorders (other than anxiety disorder)
  • Stroke Patients :
• Other upper limb disorders (bilateral stroke, peripheral neuropathy, peripheral nerve injury (s), nerve compression syndrome, myopathy, severe osteoarthritis, recent muscle injury (s), recent bone, fracture, joint replacement)
• Ongoing conditions contraindicating BTA treatment (especially respiratory disease)
• Psychiatric disorders (other than anxiety disorder)
• The subject has limb disorders (peripheral neuropathy, peripheral nerve injury (s), nerve compression syndrome, myopathy)

Egyéb

• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• The patient is pregnant or breastfeeding
• The subject is minor
• The subject is under guardianship or curatorship
• The subject has fixed retractions or bone deformities to the affected upper limb
• Subjects with an intrathecal baclofen pump
• Subjects with general anaesthesia scheduled within three months of treatment
• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• The patient is pregnant or breastfeeding
• The subject is minor
• The subject is under guardianship or curatorship
• The subject has fixed retractions or bone deformities to the affected upper limb
• Subjects with an intrathecal baclofen pump
• Subjects with general anaesthesia scheduled within three months of treatment
• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• The patient is pregnant or breastfeeding
• The subject is minor
• The subject is under guardianship or curatorship

• The patient must have given their free and informed consent and signed the consent form
• The patient must be a member or beneficiary of a health insurance plan
• The patient is available for a follow-up of up to six months
• Women and men are included
• The patient is at least 18 years old
• Subjects with upper limb spasticity involving the biceps brachial muscle, with a modified Ashworth score greater than or equal to 1, after hemorrhagic and/or ischemic stroke.
• Patients will be voluntarily selected at three months of stroke to minimize the variability in single-fiber parameters caused by the central event itself
• The patient must have given their free and informed consent and signed the consent form
• The patient must be a member or beneficiary of a health insurance plan
• The patient is available for a follow-up of up to six months
• Women and men are included
• The patient is at least 18 years old
• Subjects with upper limb spasticity involving one of elbow flexor muscle, with a modified Ashworth score greater than or equal to 1, after hemorrhagic and/or ischemic stroke.
• Patients will be voluntarily selected at three months of stroke to minimize the variability in single-fiber parameters caused by the central event itself
• The subject must have given their free and informed consent and signed the consent form
• The subject must be a member or beneficiary of a health insurance plan
• The subject should only be available on the day of recording
• Women and men are included
• The patient is at least 18 years old
• They will be matched to stroke patient by age (+/- 5 years) and sex

A regiszterben nem jelölt feltételek

• Stroke Patients :